Might not be so easy after all....From...

First 982 Last

Share
Profile

Follow
Avarice67

567 Posts.

2

14/12/22

23:31

Post #: 65316716
Share

Originally posted by Rajenp5: ↑

Anybody come across this?

Oh the bitter irony

Conviction Life Sciences Company – CLSC Initial Public Offering

https://quoteddata.com/research/conviction-life-sciences-company-clsc-initial-public-offering-qd/
Investment companies | IPO note | 22 November 2022Conviction Life Sciences Company (CLSC) has a target issuance of up to 100m ordinary shares at 100p per share as part of the company’s initial issue, equal to an initial market cap of up to £100m.CLSC is being launched to capitalise on two avenues of return presented by the global life sciences and medical technology markets, the first being the inherent structural growth opportunities which are presented by the sector, and the second being what the directors believe is a materially undervalued sector, particularly outside of the United States. CLSC’s addressable markets will include, for example, novel therapeutics (both large- and small-molecule), medical technology (including devices and diagnostics), pharmaceutical services, and digital health.

The manager
CLSC is an internally managed Alternative Investment Fund and has appointed Plain English Finance to provide certain services in relation to CLSC and its portfolio, including portfolio management, and due diligence in relation to proposed investments. Three members of Plain English Finance have been identified as the core management team: Andrew Craig, Dr Luke Zhou, and Roderick Collins.CLSC and the investment manager have formed an investment committee, which will report to the board of CLSC. The investment committee will be chaired by Geoff Miller (see page 15) and will consist of the core management team, and Dr Victoria Gordon and Geoff Miller on behalf of the board.

Expand

Might not be so easy after all....

From https://clsc.uk/

Conviction Life Sciences Company Limited (“CLSC” or the “Company”)
Extension to IPO Timetable

Further to the publication of the prospectus on 16 November 2022 (the “Prospectus”), the Company has decided to extend the offer period in respect of the Initial Placing, Offer for Subscription, Direct Subscriptions and Intermediaries Offer (the “Initial Issue”). The final date for the close of the Initial
Issue will be extended from 13 December 2022 to 31 January 2023. The detailed expected timetable is set out below. Marketing continues to progress positively, and the Board is encouraged by the interestshown for the proposition to date, reflecting the Board's opinion of the compelling fundamental characteristics of the offering. However, a number of prospective investors have asked for more time in order to complete the due diligence required which, given the convergence of the marketing period with the upcoming Christmas holiday season, has led the Board, in consultation with the Investment Manager, to extend the close of the Initial Issue to January 2023.

Last edited by Avarice67: 14/12/22
3 Upvote

Reply